Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Access to Technology and Equipment for Same-day Tests Act or the Access to TESTs Act This bill establishes grant programs to increase access to diagnostic tests. Specifically, the Centers for Disease Control and Prevention (CDC) must award grants to hospitals, primary care facilities, and other health care providers to buy equipment and supplies to increase access to same-day diagnostic testing in point-of-care settings. The CDC must also award grants to public health and other laboratories to buy high-throughput diagnostic equipment and supplies to increase testing capacity and expedite test results.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2022 · fourth_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act. H.R.2617, the Consolidated Appropriations Act, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022"; H.R. 4128/S. 2209; S. 4348 Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; The Verifying Accurate Leading-edge IVCT Development Act of 2021; Issues related to public health emergency preparedness.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022".
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
General issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
General issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; S.3799-PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0. H.R.4128 and S.2209, the VALID Act. S.3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act: H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act; H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act. H.R. 6000, CURES 2.0.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act. H.R. 747/S.1018 The Access to Technology and Equipment for Same-day Tests Act. H.R.1436/S. 308 Protecting Providers Everywhere in America Act. H.R. 3635/S. 1974 Strengthening America's Strategic National Stockpile Act H.R. 3463/S.1693 Medical Supplies for Pandemics Act. Build Back Better Reconciliation Package Issues related to public health emergency preparedness
Client expense: $175,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2021 · third_quarter · Health Issues
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act. H.R. 747/S.1018 The Access to Technology and Equipment for Same-day Tests Act. H.R.1436/S. 308 Protecting Providers Everywhere in America Act. H.R. 3635/S. 1974 Strengthening America's Strategic National Stockpile Act H.R. 3463/S.1693 Medical Supplies for Pandemics Act. Build Back Better Reconciliation Package Issues related to public health emergency preparedness
Client expense: $175,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2021 · third_quarter · Health Issues
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (HR 4128/S 2209); The Access to TESTs Act (HR 747/S1018); The Medical Supplies for Pandemics Act of 2021 (HR 3463/S 1693); The Strengthening Americas Strategic National Stockpile Act of 2021 (S. 1974).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act: H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act. H.R. 747/S.1018 The Access to Technology and Equipment for Same-day Tests Act. H.R.1436/S. 308 Protecting Providers Everywhere in America Act. H.R. 3635/S. 1974 Strengthening America's Strategic National Stockpile Act H.R. 3463/S.1693 Medical Supplies for Pandemics Act. Issues related to public health emergency preparedness
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2021 · second_quarter · Health Issues
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act. H.R. 747/S.1018 The Access to Technology and Equipment for Same-day Tests Act. H.R.1436/S. 308 Protecting Providers Everywhere in America Act. H.R. 3635/S. 1974 Strengthening America's Strategic National Stockpile Act H.R. 3463/S.1693 Medical Supplies for Pandemics Act. Issues related to public health emergency preparedness
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2021 · second_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
Issues related to diagnostic testing; "Access to TESTs Act" (H.R. 747/S. 1018); Issues related to inclusion of diagnostics in the Strategic National Stockpile; "United States Innovation and Competition Act of 2021" (S. 1260) relating to the Strategic National Stockpile; "Medical Supplies for Pandemics Act of 2021" (H.R. 3463/S. 1693).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act: S. 1693-Medical Supplies for Pandemics Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
Issues relating to COVID diagnostic testing; HR 747-Access to TESTs Act; S.1018-authorization of grants for acquiring equipment to perform same-day clinical laboratory testing in a point-of-care setting.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
Advancing H.R.747 and S.1018, the TEST Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE